Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings $21.75 -0.40 (-1.81%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$21.57 -0.18 (-0.82%) As of 02/21/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsRatings Top 50 BBC HoldingsRankCompanyCurrent PriceWeightShares Held1Bny Mellon Cash Reserve UsdN/A1.76%123,5622AKROAkero Therapeutics$51.84+2.5%1.64%2,0943SANASana Biotechnology$3.01-1.6%1.38%29,7924ORICORIC Pharmaceuticals$7.68+2.8%1.29%7,2105ETNB89bio$11.08+1.0%1.26%7,7426LQDALiquidia$16.11-2.4%1.25%5,5207VIRVir Biotechnology$9.57-2.3%1.19%8,1808VERVVerve Therapeutics$7.28-7.0%1.16%9,7559MNMDMind Medicine (MindMed)$7.63-6.7%1.11%8,65810PRAXPraxis Precision Medicines$74.49-6.3%1.06%856 Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 11SNDXSyndax Pharmaceuticals$16.38+2.4%1.02%4,51212ZYMEZymeworks$14.39+2.6%1.02%4,81613CVACCureVac$3.30+0.6%1.01%18,99214REPLReplimune Group$13.98-2.3%1.00%4,97415SMMTSummit Therapeutics$22.12-4.1%1.00%3,40216TNGXTango Therapeutics$2.36-2.9%0.99%21,32517ABCLAbCellera Biologics$3.03-3.5%0.96%20,60218COGTCogent Biosciences$8.00-1.1%0.95%7,28719SLNOSoleno Therapeutics$46.13-2.7%0.95%1,31320ANABAnaptysBio$18.62-1.3%0.93%4,04621QUREuniQure$12.84-0.9%0.93%4,03622OMEROmeros$9.18-4.5%0.92%7,15823XERSXeris Biopharma$3.75-5.5%0.92%17,87624AVBPArriVent BioPharma$27.07-1.2%0.91%2,34825CNTACentessa Pharmaceuticals$16.63-0.7%0.91%3,60326CMPSCOMPASS Pathways$4.21-7.3%0.91%13,78227RNAAvidity Biosciences$31.12-4.3%0.90%1,80028CGONCG Oncology$27.85-1.3%0.90%2,10629NGNENeurogene$17.36+0.3%0.90%2,72130PRTAProthena$15.56+2.0%0.90%4,40131RXRXRecursion Pharmaceuticals$9.28-10.3%0.90%8,70732STOKStoke Therapeutics$8.33-4.7%0.89%4,93333VRDNViridian Therapeutics$16.27-2.1%0.89%3,37934ARQTArcutis Biotherapeutics$13.02-3.0%0.88%4,96135EWTXEdgewise Therapeutics$27.07-0.1%0.88%2,15936PCVXVaxcyte$79.74-3.3%0.88%69237MRUSMerus$47.37-0.5%0.87%1,46738XENEXenon Pharmaceuticals$39.73+0.9%0.87%1,54139CAPRCapricor Therapeutics$15.00-1.0%0.86%4,23840CELCCelcuity$13.15+0.2%0.86%4,820Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y41NUVLNuvalent$79.49-3.5%0.86%70042SYRESpyre Therapeutics$21.29-5.0%0.86%2,54143ARCTArcturus Therapeutics$17.77+5.0%0.85%3,46344BEAMBeam Therapeutics$30.43-8.2%0.85%2,16645ITOSiTeos Therapeutics$7.41-0.9%0.85%7,65046CATXPerspective Therapeutics$2.79-1.9%0.85%17,51447SRRKScholar Rock$37.70-3.7%0.85%1,45948DNTHDianthus Therapeutics$23.67-0.1%0.84%2,58649ELVNEnliven Therapeutics$21.80+1.5%0.84%2,64250RVMDRevolution Medicines$41.34-2.2%0.84%1,352 Geographic ExposureUnited States86.3%Canada2.8%Netherlands2.3%Ireland1.0%Virgin Islands, British0.9%Singapore0.7%Cayman Islands0.7%Currency ExposureUSD100.1%Sector ExposureHealth Care26.3%Energy0.8%Consumer Discretionary0.7%Industry ExposureBiotechnology24.6%Diversified Consumer Services1.7%Renewable Energy0.8%Pharmaceuticals0.7%SubIndustry ExposureBiotechnology20.2%Pharmaceuticals2.2%Renewable Energy Equipment0.8%Coupon Exposure0-21.9% Related Companies and Tools Related Companies JDOC Portfolio HYLG Portfolio BIS Portfolio LGHT Portfolio RXD Portfolio PILL Portfolio FTXH Portfolio MEDI Portfolio MEDX Portfolio GDOC Portfolio This page (NYSEARCA:BBC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
